Nutriband Inc. (NASDAQ: NTRB), a company focused on developing transdermal pharmaceutical products, announced that its CEO, Gareth Sheridan, will attend the inaugural Nasdaq LaB Biotech Summit. The event is scheduled for Sept. 16, 2026, at the Nasdaq MarketSite in New York. The summit is designed to bring together biotechnology executives, investors, and industry leaders for an evening of thought leadership and networking.
This participation is significant for Nutriband as it provides a platform to showcase its innovative lead product: an abuse-deterrent fentanyl patch that incorporates the company's AVERSA™ technology. The AVERSA™ technology is designed to be integrated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. With the ongoing opioid crisis, the development of such technologies is critical in addressing public health concerns related to prescription drug abuse.
Attending the Nasdaq LaB Biotech Summit offers Nutriband an opportunity to engage with key stakeholders in the biotech and investment communities. It allows the company to highlight its progress and future plans, potentially attracting partnerships and investment that could accelerate the development and commercialization of its products. The summit's focus on networking and thought leadership aligns with Nutriband's goals of expanding its presence in the pharmaceutical industry.
The announcement comes at a time when the pharmaceutical industry is increasingly under pressure to develop safer alternatives to existing medications. Nutriband's AVERSA™ technology could set a new standard for transdermal drug delivery systems, particularly for opioids that carry a high risk of abuse. By demonstrating its commitment to safety, Nutriband positions itself as a responsible player in the market.
Investors and industry observers will be watching closely to see how Nutriband leverages this opportunity. The company's participation in such a high-profile event may signal confidence in its pipeline and business strategy. As the summit approaches, more details about Nutriband's involvement and any announcements made during the event are likely to generate interest.
For more information about Nutriband and its latest developments, interested parties can visit the company's newsroom at https://ibn.fm/NTRB. The full press release regarding the CEO's attendance can be accessed at https://ibn.fm/j4F3R.
